Moreover, in most patients with a paradoxical increase of GH during an Oral Glucose Tolerance Test (OGTT), an overexpression of the glucose-dependent insulinotropic polypeptide (GIP) receptor was found in somatotroph adenomas [11]. The gene discussed is GH1; the disease is growth hormone secreting pituitary adenoma 1.